Skip to main content
Clinical Trials/NCT06847113
NCT06847113RecruitingNot Applicable

MAXIMAL and SELF-SELECTED WALKING SPEED AFTER KNEE ARTHROPLASTY

Lovisenberg Diakonale Hospital1 site in 1 country130 target enrollmentStarted: November 20, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
130
Locations
1
Primary Endpoint
Change from baseline to 3 and 12 months in means in maximal and self-selected walking speed walikgn

Study Overview

Brief Summary

The purpose of this prospective study is to explore whether maximal and self-selected walking speed in individuals with knee arthroplasty is a useful and applicable clinical measure that can provide new insights into physical function after prosthetic surgery. We will examine the progression of walking speed and other measures of physical function, and investigate if walking speed can predict postoperative function. Individuals over 55 years, scheduled for knee arthroplasty will be invited to participate. Standardized functional tests such as walking speed, sit to stand and one legged stance along with patient reported outcomes will be assessed preoperatively, three months and 12 months after surgery. The study may provide useful knowledge that can be aplied clinically in the assessment and follow-up of this patient group.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
55 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age 55 +, living in or near the city of Oslo (up to appox 2 hours commute), sceduled for primary knee arthroplasty, able to walk independently with or without walking aids, understand and speak Norwegian sufficently to take instructions and respond to questionnaires

Exclusion Criteria

  • •Other reasons than osteoarthritis for knee arthroplasty, revision due to infection or failure, arthroplasty in the same or other limb during the 12 months time period, severe neurological or ohter types of disease that affects walking (e.g MS; parkinsonism, hemiplegiea)

Outcomes

Primary Outcomes

Change from baseline to 3 and 12 months in means in maximal and self-selected walking speed walikgn

Time Frame: Baseline, 3 months and 12 months after surgery

Walking speed will be measured by 10 meter self-selected and maximal walking speed, respectively. Participant will perform two repetitions of self-selected walking speed, followed by two repetitions of maximal walking speed. Mean, measured by meters per seconds, will be calculated onboth of the two different walking speeds.

Secondary Outcomes

  • Sit-to-stand(Baseline, 3 months and 12 months after surgery)
  • One legged stance(Baseline, 3 months and 12 months after surgery)
  • Knee specific function and pain(Baseline and 12 months)
  • EQ5D- Health-related quality of life(Baseline and 12 months after surgery)

Investigators

Sponsor
Lovisenberg Diakonale Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials